High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma

Respiratory Medicine

Volumn 103, Issue 3, 2009, Pages 379-385

  Zietkowski, Ziemowit ^a   Tomasiak Lozowska, Maria M ^a   Skiepko, Roman ^a   Mroczko, Barbara ^a   Szmitkowski, Maciej ^a   Bodzenta Lukaszyk, Anna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Airway inflammation; Asthma; Exhaled breath condensate; Exhaled nitric oxide; High sensitivity C reactive protein

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; NITRIC OXIDE; STEROID;

ADULT; ARTICLE; ASTHMA; BREATH ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADMINISTRATION, INHALATION; ADULT; ANALYSIS OF VARIANCE; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; BRONCHIAL HYPERREACTIVITY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHRONIC DISEASE; EOSINOPHILIA; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; SENSITIVITY AND SPECIFICITY;

EID: 59349093724     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.10.003     Document Type: Article

References (33)

1. Busse W.W., and Lemanske R.F. Asthma. N Engl J Med 344 (2001) 350-362
2. Jousilahti P., Salomaa V., Hakala K., et al. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 89 (2002) 381-385
3. Buyukozturk S., Gelincik A.A., Genc S., et al. Acute phase reactions in allergic airway disease. Tohuku J Exp Med 204 (2004) 209-213
4. Pepys M.B. C-reactive protein fifty years on. Lancet (1981) 653-657
5. Nakayama T., Sonoda S., Urano T., et al. Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infections diseases. Clin Chem 39 (1993) 293-297
6. Baumann H., and Gauldie J. The acute phase response. Immunol Today 15 (1994) 74-80
7. Gewurz H., Mold C., Siegal J., et al. C-reactive protein and the acute phase response. Adv Intern Med 27 (1982) 345-372
8. Pepys M.B., and Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 111 (2003) 1805-1812
9. Tall A.R. C-reactive protein reassessed. N Engl J Med 350 14 (2004) 1450-1452
10. Tracy R.P. Inflammation in cardiovascular disease: cart, horse, or both?. Circulation 97 (1998) 2000-2002
11. Rifai N., Tracy R.P., and Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45 (1999) 2136-2141
12. Takemura M., Matsumoto H., Niimi A., et al. High sensitivity C-reactive protein in asthma. Eur Respir J 27 (2006) 908-912
13. Fujita M., Ueki S., Ito W., et al. C-reactive protein levels in the serum of asthmatic patients. Ann Allergy Asthma Immunol 99 (2007) 48-53
14. Horvath I., Hunt J., and Barnes P.J. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26 (2005) 523-548
15. Global Initiative for Asthma. Global strategy for asthma management and prevention: NHLBI/WHO Report 2005, publication 02-3659. www.ginasthma.org.
16. American Thoracic Society/American Lung Association Recommendations for On-line Measurement of Exhaled Nitric Oxide in Adults and the Recommendations for On-line, Offline and Nasal Expired Nitric Oxide Measurements in Children. Am J Respir Crit Care Med 160 (1999) 2104-2117
17. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144 (1991) 1202-1218
18. Rahman I., and Biswas S. Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues. Redox Rep 9 3 (2004) 125-143
19. Multu G.M., Garey K.W., Robbins R.A., et al. Collection and analysis of exhaled breath condensate in humans. Am Respir Crit Care Med 164 (2001) 731-737
20. Kony S., Zureik M., Driss F., et al. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 59 (2004) 892-896
21. Olafsdottir I.S., Gislason T., Thjodleifsson B., et al. C-reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 60 (2005) 451-454
22. Yudkin J.S., Stehouwer C.D.A., Emeis J.J., et al. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
23. Ridker P.M. High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103 (2001) 1813-1818
24. Nakamura H., and Yamashita T. Predictive value of cardiovascular events by high sensitivity CRP. Nippon Rinsho 60 (2002) 916-921
25. Rosias P.P.R., Dompeling E., Dentener M.A., et al. Childhood asthma: Exhaled markers of airway inflammation, asthma control score and lung function score. Pediatr Pulmonol 38 (2004) 107-114
26. Ueno T., Kataoka M., Hirano A., et al. Inflammatory markers in exhaled breath condensate from patients with asthma. Respirology 13 (2008) 654-663
27. Qian F.-H., Zhang Q., Zhou L.-F., et al. High-sensitivity C-reactive protein: A predictive marker in severe asthma. Respirology 13 (2008) 664-669
28. Wolbink G.J., Brouwer M.C., Buysmann S., et al. CRP-mediated activation of complement in vivo: assessment by measuring complement-C-reactive protein complexes. J Immunol 157 (1996) 473-479
29. Muller H., and Fehr J. Binding of C-reactive protein to human polymorphonuclear leukocytes: evidence for association of binding sites with Fc receptors. J Immunol 136 (1986) 2202-2207
30. Marnell L.L., Mold C., Volzer M.A., et al. C-reactive protein binds to Fc gamma RI in transfected COS cells. J Immunol 155 (1995) 2185-2193
31. Deveraj S., Du Clos T.W., and Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors of human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol 25 (2005) 1359-1363
32. Filep J.G., Herman F., Kelemen E., et al. C-reactive protein inhibits binding of platelet-activating factor to human platelets. Thromb Res 61 (1991) 411-421
33. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 14 (2004) 1387-1397